MOH Stock Analysis: Buy, Sell, or Hold?

MOH - Molina Healthcare, Inc.

HOSPITAL & MEDICAL SERVICE PLANS
$200.29
3.35 (1.70%) ▲
5d: -5.71%
30d: +0.0%
90d: +10.5%
WAIT
LOW Confidence
Protect Your MOH Gains
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Oct 21, 2026

Get Alerted When MOH Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: MOH is fairly priced but lacks strong directional signals. At 3.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$351.35
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$218.16
8.2% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.1x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: MOH is currently trading at $200.29, which is considered fair relative to its 30-day fair value range of $192.68 to $217.38. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.4) compared to its historical average (21.1). At these levels, the market is pricing in 3.6% annual earnings growth.

Technical Outlook: Technically, MOH is in a strong downtrend. Immediate support is located at $194.08, while resistance sits at $214.83.

Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $192.68 - $217.38
Company Quality Score 38/100 (SELL)
Volume Confirmation HIGH
Confidence Score 76.5%

Protect Your Profits

Holding MOH? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (44/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($209.12)
  • BULLISH: Expecting earnings turnaround to 3.6% growth with -5.7% revenue growth
  • WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $192.68 - $217.38
Current vs Trading Range FAIR
Expected Move (7 Days) Âą$10.97 (5.5%)

Support & Resistance Levels

Support Level $194.08
Resistance Level $214.83
Current Trend Strong Downtrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 23.42
Wall Street Target $209.12 (+4.4%)
Revenue Growth (YoY) -5.7%
Earnings Growth (YoY) -75.3%
Valuation Premium vs History +3.6% premium
PE vs Historical 23.4 vs 21.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +3.6% (market-implied from PE analysis)
1-Year Target $207.50 (+4%)
2-Year Target $214.97 (+7%)
3-Year Target $222.71 (+11%)
3-Yr Target (if PE normalizes) (PE: 23→21) PE COMPRESSION $200.62 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 23.4, Growth: 63.1%) $675.98 (+238%)
Base: (SPY PE: 20.1, Growth: 63.1%) $579.21 (+189%)
Bear: (PE: 17.1, Growth: 63.1%) $492.33 (+146%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Forward PE: 38.17 | Forward EPS (Implied): $5.25
Bull Case $241.85 (+21%)
Analyst growth 15.0%, PE expands to 40.1
Base Case $200.29 (0%)
Market implied 0.0%, PE stable at 38.2
Bear Case $153.22 (-24%)
Severe decline -15.0%, PE contracts to 34.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 23, 2026 7:38 PM ET
Data refreshes hourly during market hours. Next update: 8:38 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna SELL 2026-03-30

Unlock Insider Activity

See real-time buying/selling by company executives for MOH.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CVS
CVS Health Corp
STRONG BUY
28 analysts
$116 65 BUY
UNH
UnitedHealth Group Incorâ€Ļ
STRONG BUY
27 analysts
$475 50 HOLD
CI
Cigna Corp
STRONG BUY
25 analysts
$341 48 HOLD
ELV
Elevance Health Inc
STRONG BUY
22 analysts
$449 54 HOLD
HUM
Humana Inc
HOLD
26 analysts
$416 60 BUY

Advanced MOH Option Strategies

Professional options setups generated by AI based on today's MOH price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for MOH

MOH Technical Chart MOH Price Prediction MOH Earnings Date MOH Investment Advisor MOH Fair Price Analyzer MOH Options Advisor MOH Options Chain MOH Options Analysis MOH Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals